tradingkey.logo
tradingkey.logo
Search

IDEAYA Biosciences Inc

IDYA
Add to Watchlist
35.500USD
-0.900-2.47%
Close 07-31 16:00ETQuotes delayed by 15 min
3.38BMarket Cap
LossP/E TTM

IDYA Income Statement

You can find the annual or quarterly income statement of IDEAYA Biosciences Inc here for insights into the performance and operational efficiency of IDEAYA Biosciences Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q3
FY2018Q2
FY2018Q1
Total revenue
--6.56M
55.37%10.88M
--207.83M
----
--0.00
78.48%7.00M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-2.49%3.92M
-72.94%8.04M
-39.43%3.54M
-30.63%7.88M
35.79%4.02M
230.87%29.70M
-33.18%5.85M
56.74%11.36M
-71.98%2.96M
0.10%8.98M
--8.76M
--7.25M
--10.57M
--8.97M
----
----
----
----
----
----
----
----
----
Revenue
--6.56M
55.37%10.88M
--207.83M
----
--0.00
78.48%7.00M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-2.49%3.92M
-72.94%8.04M
-39.43%3.54M
-30.63%7.88M
35.79%4.02M
230.87%29.70M
-33.18%5.85M
56.74%11.36M
-71.98%2.96M
0.10%8.98M
--8.76M
--7.25M
--10.57M
--8.97M
----
----
----
----
----
----
----
----
----
Operating expenses
36.40%115.10M
-30.23%105.45M
48.57%99.38M
36.78%88.81M
65.41%84.39M
229.71%151.14M
60.94%66.89M
79.09%64.93M
49.35%51.02M
50.46%45.84M
43.13%41.56M
27.88%36.25M
33.54%34.16M
42.82%30.46M
40.36%29.04M
43.13%28.35M
56.14%25.58M
34.57%21.33M
48.17%20.69M
57.32%19.81M
31.29%16.38M
40.04%15.85M
20.13%13.96M
12.06%12.59M
23.62%12.48M
--11.32M
-14.70%11.62M
48.40%11.23M
65.83%10.09M
--13.63M
--7.57M
--6.09M
R&D expenses
35.04%95.73M
-38.22%86.60M
45.21%82.99M
36.11%74.23M
65.60%70.89M
261.58%140.18M
69.59%57.15M
86.90%54.53M
53.65%42.80M
56.88%38.77M
50.64%33.70M
28.00%29.18M
41.73%27.86M
53.40%24.71M
44.31%22.37M
52.19%22.80M
69.95%19.66M
33.68%16.11M
54.64%15.50M
74.26%14.98M
28.14%11.57M
41.10%12.05M
12.35%10.03M
-2.97%8.60M
12.88%9.03M
--8.54M
-28.83%8.92M
37.73%8.86M
53.71%8.00M
--12.54M
--6.43M
--5.20M
Depreciation, depletion, and amortization
16.67%700.00K
20.17%721.00K
16.67%700.00K
15.43%718.00K
-2.60%600.00K
-14.29%600.00K
-6.25%600.00K
0.48%622.00K
2.67%616.00K
16.67%700.00K
12.48%640.00K
21.37%619.00K
29.31%600.00K
33.93%600.00K
13.80%569.00K
14.86%510.00K
16.00%464.00K
12.00%448.00K
44.09%500.00K
11.00%444.00K
19.05%400.00K
21.21%400.00K
7.10%347.00K
34.23%400.00K
14.68%336.00K
--330.00K
45.29%324.00K
43.96%298.00K
51.81%293.00K
--223.00K
--207.00K
--193.00K
Operating profit
-28.62%-108.54M
34.39%-94.57M
262.13%108.45M
-36.78%-88.81M
-65.41%-84.39M
-243.87%-144.14M
-99.53%-66.89M
-98.50%-64.93M
-94.14%-51.02M
-58.52%-41.92M
-5179.70%-33.53M
-45.38%-32.71M
-84.80%-26.28M
-43.95%-26.44M
105.63%660.00K
-103.59%-22.50M
-55.67%-14.22M
-247.90%-18.37M
-134.45%-11.71M
12.22%-11.05M
26.79%-9.13M
53.35%-5.28M
57.02%-5.00M
-12.06%-12.59M
-23.62%-12.48M
---11.32M
14.70%-11.62M
-48.40%-11.23M
-65.83%-10.09M
---13.63M
---7.57M
---6.09M
Net non-operating interest income (expenses)
Non-operating interest income
-18.07%10.01M
-18.29%11.30M
-28.40%10.79M
-6.91%11.31M
6.69%12.21M
73.65%13.83M
147.65%15.07M
154.13%12.15M
333.69%11.45M
255.13%7.96M
537.28%6.09M
979.68%4.78M
1174.88%2.64M
1328.03%2.24M
629.01%955.00K
325.96%443.00K
81.58%207.00K
8.28%157.00K
87.14%131.00K
-47.74%104.00K
-73.79%114.00K
-72.95%145.00K
-89.30%70.00K
-65.27%199.00K
-17.14%435.00K
--536.00K
14.14%654.00K
0.88%573.00K
86.17%525.00K
--573.00K
--568.00K
--282.00K
Other non-operating income (expenses)
--0.00
--11.30M
--10.79M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--2.00K
-100.00%0.00
-25.00%6.00K
-100.00%0.00
--1.00K
--8.00K
--68.00K
Income before tax
-36.52%-98.54M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-82.40%-72.18M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
-67.39%-39.57M
-40.30%-33.95M
-1799.07%-27.44M
-26.61%-27.93M
-68.70%-23.64M
-32.88%-24.20M
113.94%1.61M
-101.48%-22.06M
-55.34%-14.01M
-254.66%-18.21M
-135.12%-11.58M
11.65%-10.95M
25.09%-9.02M
52.37%-5.13M
55.09%-4.93M
-16.28%-12.39M
-25.85%-12.04M
---10.78M
15.96%-10.97M
-52.34%-10.66M
-66.79%-9.57M
---13.05M
---7.00M
---5.74M
Income tax
--0.00
----
----
--0.00
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-36.52%-98.54M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-82.40%-72.18M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
-67.39%-39.57M
-40.30%-33.95M
-1799.07%-27.44M
-26.61%-27.93M
-68.70%-23.64M
-32.88%-24.20M
113.94%1.61M
-101.48%-22.06M
-55.34%-14.01M
-254.66%-18.21M
-135.12%-11.58M
11.65%-10.95M
25.09%-9.02M
52.37%-5.13M
55.09%-4.93M
-16.28%-12.39M
-25.85%-12.04M
---10.78M
15.96%-10.97M
-52.34%-10.66M
-66.79%-9.57M
---13.05M
---7.00M
---5.74M
Net income from continuous operations
-36.52%-98.54M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-82.40%-72.18M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
-67.39%-39.57M
-40.30%-33.95M
-1799.07%-27.44M
-26.61%-27.93M
-68.70%-23.64M
-32.88%-24.20M
113.94%1.61M
-101.48%-22.06M
-55.34%-14.01M
-254.66%-18.21M
-135.12%-11.58M
11.65%-10.95M
25.09%-9.02M
52.37%-5.13M
55.09%-4.93M
-16.28%-12.39M
-25.85%-12.04M
---10.78M
15.96%-10.97M
-52.34%-10.66M
-66.79%-9.57M
---13.05M
---7.00M
---5.74M
Net income attributable to controlling interests
-36.52%-98.54M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-82.40%-72.18M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
-67.39%-39.57M
-40.30%-33.95M
-1799.07%-27.44M
-26.61%-27.93M
-68.70%-23.64M
-32.88%-24.20M
113.94%1.61M
-101.48%-22.06M
-55.34%-14.01M
-254.66%-18.21M
-135.12%-11.58M
11.65%-10.95M
25.09%-9.02M
52.37%-5.13M
55.09%-4.93M
-16.28%-12.39M
-25.85%-12.04M
---10.78M
15.96%-10.97M
-52.34%-10.66M
-66.79%-9.57M
---13.05M
---7.00M
---5.74M
Net income attributable to common shareholders
-36.52%-98.54M
36.10%-83.27M
330.11%119.24M
-46.84%-77.49M
-82.40%-72.18M
-283.78%-130.31M
-88.85%-51.82M
-88.97%-52.77M
-67.39%-39.57M
-40.30%-33.95M
-1799.07%-27.44M
-26.61%-27.93M
-68.70%-23.64M
-32.88%-24.20M
113.94%1.61M
-101.48%-22.06M
-55.34%-14.01M
-254.66%-18.21M
-135.12%-11.58M
11.65%-10.95M
25.09%-9.02M
52.37%-5.13M
55.09%-4.93M
-16.28%-12.39M
-25.85%-12.04M
---10.78M
15.96%-10.97M
-52.34%-10.66M
-66.79%-9.57M
---13.05M
---7.00M
---5.74M
Basic earnings per share
-35.99%-1.11
36.96%-0.94
324.03%1.35
-29.40%-0.88
-55.05%-0.82
-186.93%-1.49
-31.47%-0.60
-36.35%-0.68
-7.80%-0.53
-3.53%-0.52
-1241.35%-0.46
12.98%-0.50
-34.60%-0.49
-6.23%-0.50
113.07%0.04
-71.22%-0.57
-27.84%-0.36
-168.56%-0.47
-76.77%-0.31
43.53%-0.33
52.24%-0.28
66.86%-0.18
68.12%-0.17
-12.22%-0.59
-21.06%-0.59
---0.53
18.79%-0.54
-46.40%-0.53
-66.79%-0.49
---0.67
---0.36
---0.29
Diluted earnings per share
-35.99%-1.11
36.96%-0.94
321.12%1.33
-29.40%-0.88
-55.05%-0.82
-186.93%-1.49
-31.47%-0.60
-36.35%-0.68
-7.80%-0.53
-3.53%-0.52
-1264.01%-0.46
12.98%-0.50
-34.60%-0.49
-6.23%-0.50
112.81%0.04
-71.22%-0.57
-27.84%-0.36
-168.56%-0.47
-76.77%-0.31
43.53%-0.33
52.24%-0.28
66.86%-0.18
68.12%-0.17
-12.22%-0.59
-21.06%-0.59
---0.53
18.79%-0.54
-46.40%-0.53
-66.79%-0.49
---0.67
---0.36
---0.29
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read IDEAYA Biosciences Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing IDYA stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was IDEAYA Biosciences Inc's revenue at year end?

IDEAYA Biosciences Inc reported 218.71M in revenue for fiscal year 2025, up from 7.00M in the previous year.

What was IDEAYA Biosciences Inc's net income for the year?

IDEAYA Biosciences Inc posted -113.70M in net income for fiscal year 2025.

How much net income did IDEAYA Biosciences Inc post in the last quarter?

IDEAYA Biosciences Inc reported -98.54M in net income for the latest quarter。

What was IDEAYA Biosciences Inc's annual operating profit?

IDEAYA Biosciences Inc's operating income was -159.31M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.